drugset / Trial / NCT07656753

Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy

NCT07656753 ↗

Phase 0 Recruiting 6 enrolled Peking Union Medical College Hospital
Non-randomizedSequentialOpen-labelTreatment

Summary

The goal of this clinical trial is to evaluate the safety and efficacy of PUMCH-E111 injection in subjects with RLBP1 related Inherited Retinal Dystrophy.

Timeline

Start
2026-02-03
Primary completion
2027-06-30
Completion
2031-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject PUMCH-E111 Unknown — Intravitreal